Institutional investors hold a majority ownership of BMY through the 71.59% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended September 2017, these large investors purchased a net $11.9 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ORBIS INVESTMENT MANAGEMENT LTD. Bought 5.3 Million shares of Bristol-Myers Squibb
JENNISON ASSOCIATES LLC Bought 3.7 Million shares of Bristol-Myers Squibb
INVESCO ADVISERS, INC. Bought 3.6 Million shares of Bristol-Myers Squibb